When should healthcare teams prioritise microsegmentation over broad network redesign?

Why This Matters for Security Teams

Healthcare environments rarely allow a clean-slate network redesign. Clinical uptime, legacy medical devices, vendor-managed systems, and tightly coupled workflows make large-scale readdressing or enclave rebuilding slow and disruptive. Microsegmentation becomes a practical risk-reduction measure when the immediate problem is lateral movement, not just perimeter exposure. It narrows access between workloads, devices, and service zones so that a compromised endpoint or unmanaged clinical device cannot freely traverse the environment.

This is especially important in healthcare because many assets cannot be patched quickly, support modern agents, or tolerate prolonged maintenance windows. Identity-aware segmentation can reduce blast radius while preserving clinical operations, which aligns with the direction of NIST SP 800-207 Zero Trust Architecture. The common mistake is treating segmentation as a pure infrastructure project when the real control objective is access restriction based on trust, workload role, and sensitivity.

In practice, many security teams encounter the need for segmentation only after ransomware has already moved through flat network paths, rather than through intentional resilience planning.

How It Works in Practice

Microsegmentation works best when it is tied to business context, identity, and service relationships rather than to coarse IP ranges alone. In healthcare, that often means mapping which systems need to talk to each other, then enforcing policy at the host, virtual switch, container, or software-defined network layer. The objective is not to redesign everything at once, but to create smaller trust zones around critical clinical, administrative, and research assets.

A practical rollout usually starts with asset discovery and traffic baselining. Security teams identify high-value systems such as electronic health records, imaging platforms, lab systems, and connected medical devices, then define allowed flows. Policies should be explicit, tested in monitor mode where possible, and gradually enforced to reduce care disruption. Alignment with NIST SP 800-53 Rev 5 Security and Privacy Controls helps translate this into operational controls for least privilege, boundary protection, and monitoring.

• Start with crown-jewel systems and high-risk device segments.
• Use application and identity context where available, not just subnet boundaries.
• Validate rules against normal clinical workflows before enforcement.
• Log denied traffic so security teams can tune policy and spot misconfigurations.
• Coordinate changes with biomedical engineering, IT operations, and clinical leadership.

Where this becomes especially useful is in mixed environments that include legacy operating systems, unmanaged IoMT devices, and vendor-supported systems that cannot easily be rebuilt. These controls tend to break down when segmentation is imposed on networks with poorly understood east-west dependencies because legitimate care traffic is often more complex than initial discovery suggests.

Common Variations and Edge Cases

Tighter segmentation often increases operational overhead, requiring organisations to balance reduced blast radius against change-management effort and troubleshooting complexity. That tradeoff matters in healthcare because availability and patient care continuity can outweigh the appeal of a full architectural redesign. Current guidance suggests prioritising microsegmentation first when the environment contains legacy devices, shared infrastructure, or limited maintenance windows, while reserving broader redesign for longer-term modernization.

There is no universal standard for where segmentation boundaries should sit. Some teams segment by application, some by device class, and some by clinical function. The right choice depends on which flows are stable enough to govern and which systems can tolerate policy enforcement without breaking workflows. In highly regulated settings, segmentation decisions should also support auditability, incident containment, and recovery planning. A ZTA approach helps, but it does not eliminate the need for practical exceptions during implementation.

Microsegmentation is usually the better first move when the priority is reducing immediate exposure in a live environment. Broad network redesign makes more sense when there is already a funded modernization program, a manageable asset base, and enough operational tolerance to replatform securely. For healthcare, that often means using microsegmentation as the near-term control and network redesign as the later programmatic objective.

For teams comparing control depth against operational feasibility, the more realistic question is often not whether segmentation is ideal, but whether the environment can support a safer transition without interrupting clinical care.

Related resources from NHI Mgmt Group

• When should teams prioritise CI/CD hardening over broader secret scanning?
• When should teams prioritise NHI governance over other IAM work?
• Should teams prioritise runtime controls over more vulnerability scanning?
• When should organisations prioritise privileged access management over network controls in supply chains?